Development of sulconazole-loaded nanoemulsions for enhancement of transdermal permeation and antifungal activity

Qing Yang,1,2,* Shanshan Liu,3,* Yongwei Gu,1,2 Xiaomeng Tang,3 Ting Wang,1,2 Jianhua Wu,4 Jiyong Liu1–31Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, People’s Republic of China; 2Department of Oncology, Shanghai Medical College, Fudan Universi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yang Q, Liu S, Gu Y, Tang X, Wang T, Wu J, Liu J
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	Sulconazole nanoemulsion central composite design transdermal delivery antifungal activity Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/28120add7cd64160b5b97449b919259d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:28120add7cd64160b5b97449b919259d
record_format	dspace
spelling	oai:doaj.org-article:28120add7cd64160b5b97449b919259d2021-12-02T07:22:40ZDevelopment of sulconazole-loaded nanoemulsions for enhancement of transdermal permeation and antifungal activity1178-2013https://doaj.org/article/28120add7cd64160b5b97449b919259d2019-05-01T00:00:00Zhttps://www.dovepress.com/development-of-sulconazole-loaded-nanoemulsions-for-enhancement-of-tra-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Qing Yang,1,2,* Shanshan Liu,3,* Yongwei Gu,1,2 Xiaomeng Tang,3 Ting Wang,1,2 Jianhua Wu,4 Jiyong Liu1–31Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, People’s Republic of China; 2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, People’s Republic of China; 3Department of Pharmacy, Changhai Hospital, Second Military Medical University, Shanghai 200433, People’s Republic of China; 4Department of Dermatology, Changhai Hospital, Second Military Medical University, Shanghai 200433, People’s Republic of China*These authors contributed equally to this workBackground: Sulconazole (SCZ) is a broad-spectrum transdermally administered anti-fungicidal agent. However, the therapeutic effect of SCZ is generally limited by its poor water solubility. This present study aimed to develop and evaluate sulconazole-loaded nanoemulsions (SCZ-NEs) for enhancement of the transdermal permeation and antifungal activity.Methods: A spontaneous titration method was applied to prepare the SCZ-NEs. And the optimized formulation of SCZ-NEs was screened by central composite design (CCD). In addition, the characteristics of the SCZ-NEs were evaluated, including particle size, zeta potential, drug loading (DL%) and encapsulation efficiency (EE%). The morphology of SCZ-NEs was observed by transmission electron microscopy (TEM). Franz diffusion cells were used to evaluate the transdermal permeability of the SCZ-NEs. The antifungal activity of the SCZ-NEs was measured by a zone of inhibition (ZOI) test.Results: The optimized SCZ-NEs possessed a moderate particle size of 52.3±3.8 nm, zeta potential of 23.3±1.2 mV, DL% of 0.47±0.05% and EE% of 87.1±3.2%. The ex vivo skin permeation study verified that the cumulative permeability (Qn) and penetration rate (Js) of the optimized SCZ-NEs were about 1.7-fold higher than that of a commercial reference, miconazole (MCZ) cream and 3-fold higher than that of SCZ-DMSO solution. The optimized SCZ-NEs exhibited zone of inhibition (ZOI) values of 23.5±2.4 and 20.4±2.5 mm against C. albicans and T. rubrum, which were larger compared with these of the MCZ cream and SCZ-DMSO solution.Conclusion: SCZ-NEs were effectively developed to overcome the poor solubility of SCZ, promote SCZ permeation through the skin and improve its antifungal activity. Thus, the SCZ-NEs are a promising percutaneous administration for skin fungal infections induced by C. albicans and T. rubrum.Keywords: sulconazole, nanoemulsion, central composite design, transdermal delivery, antifungal activityYang QLiu SGu YTang XWang TWu JLiu JDove Medical PressarticleSulconazolenanoemulsioncentral composite designtransdermal deliveryantifungal activityMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 3955-3966 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	Sulconazole nanoemulsion central composite design transdermal delivery antifungal activity Medicine (General) R5-920
spellingShingle	Sulconazole nanoemulsion central composite design transdermal delivery antifungal activity Medicine (General) R5-920 Yang Q Liu S Gu Y Tang X Wang T Wu J Liu J Development of sulconazole-loaded nanoemulsions for enhancement of transdermal permeation and antifungal activity
description	Qing Yang,1,2,* Shanshan Liu,3,* Yongwei Gu,1,2 Xiaomeng Tang,3 Ting Wang,1,2 Jianhua Wu,4 Jiyong Liu1–31Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, People’s Republic of China; 2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, People’s Republic of China; 3Department of Pharmacy, Changhai Hospital, Second Military Medical University, Shanghai 200433, People’s Republic of China; 4Department of Dermatology, Changhai Hospital, Second Military Medical University, Shanghai 200433, People’s Republic of China*These authors contributed equally to this workBackground: Sulconazole (SCZ) is a broad-spectrum transdermally administered anti-fungicidal agent. However, the therapeutic effect of SCZ is generally limited by its poor water solubility. This present study aimed to develop and evaluate sulconazole-loaded nanoemulsions (SCZ-NEs) for enhancement of the transdermal permeation and antifungal activity.Methods: A spontaneous titration method was applied to prepare the SCZ-NEs. And the optimized formulation of SCZ-NEs was screened by central composite design (CCD). In addition, the characteristics of the SCZ-NEs were evaluated, including particle size, zeta potential, drug loading (DL%) and encapsulation efficiency (EE%). The morphology of SCZ-NEs was observed by transmission electron microscopy (TEM). Franz diffusion cells were used to evaluate the transdermal permeability of the SCZ-NEs. The antifungal activity of the SCZ-NEs was measured by a zone of inhibition (ZOI) test.Results: The optimized SCZ-NEs possessed a moderate particle size of 52.3±3.8 nm, zeta potential of 23.3±1.2 mV, DL% of 0.47±0.05% and EE% of 87.1±3.2%. The ex vivo skin permeation study verified that the cumulative permeability (Qn) and penetration rate (Js) of the optimized SCZ-NEs were about 1.7-fold higher than that of a commercial reference, miconazole (MCZ) cream and 3-fold higher than that of SCZ-DMSO solution. The optimized SCZ-NEs exhibited zone of inhibition (ZOI) values of 23.5±2.4 and 20.4±2.5 mm against C. albicans and T. rubrum, which were larger compared with these of the MCZ cream and SCZ-DMSO solution.Conclusion: SCZ-NEs were effectively developed to overcome the poor solubility of SCZ, promote SCZ permeation through the skin and improve its antifungal activity. Thus, the SCZ-NEs are a promising percutaneous administration for skin fungal infections induced by C. albicans and T. rubrum.Keywords: sulconazole, nanoemulsion, central composite design, transdermal delivery, antifungal activity
format	article
author	Yang Q Liu S Gu Y Tang X Wang T Wu J Liu J
author_facet	Yang Q Liu S Gu Y Tang X Wang T Wu J Liu J
author_sort	Yang Q
title	Development of sulconazole-loaded nanoemulsions for enhancement of transdermal permeation and antifungal activity
title_short	Development of sulconazole-loaded nanoemulsions for enhancement of transdermal permeation and antifungal activity
title_full	Development of sulconazole-loaded nanoemulsions for enhancement of transdermal permeation and antifungal activity
title_fullStr	Development of sulconazole-loaded nanoemulsions for enhancement of transdermal permeation and antifungal activity
title_full_unstemmed	Development of sulconazole-loaded nanoemulsions for enhancement of transdermal permeation and antifungal activity
title_sort	development of sulconazole-loaded nanoemulsions for enhancement of transdermal permeation and antifungal activity
publisher	Dove Medical Press
publishDate	2019
url	https://doaj.org/article/28120add7cd64160b5b97449b919259d
work_keys_str_mv	AT yangq developmentofsulconazoleloadednanoemulsionsforenhancementoftransdermalpermeationandantifungalactivity AT lius developmentofsulconazoleloadednanoemulsionsforenhancementoftransdermalpermeationandantifungalactivity AT guy developmentofsulconazoleloadednanoemulsionsforenhancementoftransdermalpermeationandantifungalactivity AT tangx developmentofsulconazoleloadednanoemulsionsforenhancementoftransdermalpermeationandantifungalactivity AT wangt developmentofsulconazoleloadednanoemulsionsforenhancementoftransdermalpermeationandantifungalactivity AT wuj developmentofsulconazoleloadednanoemulsionsforenhancementoftransdermalpermeationandantifungalactivity AT liuj developmentofsulconazoleloadednanoemulsionsforenhancementoftransdermalpermeationandantifungalactivity
_version_	1718399446319890432

Development of sulconazole-loaded nanoemulsions for enhancement of transdermal permeation and antifungal activity

Ejemplares similares